Celiac disease: A model disease for gene-environment interaction

Cellular and Molecular Immunology

Volumn 8, Issue 2, 2011, Pages 93-95

  Uibo, Raivo ^a   Tian, Zhigang ^b   Gershwin, M Eric ^c  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

autoimmunity; Environment and autoimmunity; geoepidemiology

Indexed keywords

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CELIAC DISEASE; CLINICAL FEATURE; DISEASE COURSE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HLA TYPING; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INTESTINE INJURY; NONHUMAN; PUBLICATION; REVIEW; SOCIAL ASPECT;

ANIMALS; CELIAC DISEASE; DISEASE PROGRESSION; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GLUTENS; HLA-DQ ANTIGENS; HUMANS; INTESTINAL MUCOSA; MODELS, BIOLOGICAL;

EID: 79952374799     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.62     Document Type: Review

References (62)

1. Anderson DM. History of celiac disease. J Am Diet Assoc 1959; 35: 1158-1162.
2. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009; 137: 1912-1933.
3. Catassi C, Rätsch IM, Gandolfi L, Pratesi R, Fabiani E, El Asmar R et al. Why iscoeliac diseaseendemic in the people of theSahara? Lancet 1999; 354: 647-648. (Pubitemid 29391433)
4. Marsh MN, Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102: 330-354.
5. Jabri B, Sollid LM. Tissue-mediated control of immunopathology of coeliac disease. Nature Rev Immunol 2009; 9: 58-70.
6. Vorobjova T, Uibo O, Heilman K, RägoT, Honkanen J, Vaarala O et al. Increased FOXP3 expression insmall-bowel mucosaof children withcoeliacdiseaseandtype 1 diabetes mellitus. Scand J Gastroenterol 2009; 44: 422-430.
7. Lindfors K, Mäki M, Kaukinen K. Transglutaminase 2-targeted autoantibodies in celiac disease: pathogenetic players in addition to diagnostic tools? Autoimmune Rev 2010; 9: 744-749.
8. Zhernakova A, Elbers CC, Ferwerda B, Romanos J, Trynka G, Dubois PC et al. Evolutionary and fuctional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Gen 2010; 86: 970-977.
9. Trynka G, Wijmenga C, vanHeel DA. Agenetic perspectiveon coeliacdisease. Trends Mol Med 2010; 16: 537-550.
10. Plot L, Amital H, Barzilai O, Ram M, Nicola B, Shoenfeld Y. Infections may have a protective role in the etiopathogenesis of celiac disease. Ann NY Acad Sci 2009; 1173: 670-674.
11. Ou G, Hedberg M, Hörstedt P, Baranov V, Forsberg G, Drobni M et al. Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease. Am J Gastroenterol 2009; 104: 3058-3067.
12. de Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. Pivotal advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J Leukoc Biol 2010; 87: 765-778.
13. Meresse B, Ripoche J, Heyman M, Cerf-Bensussan N. Celiac disease: from oral toleranceto intestinal inflammation, autoimmunity and lymphogenesis. Mucosal Immunol 2009; 2: 8-23.
14. Monteleone G, Pender SL, Alstead E, Hauer AC, Lionetti P, McKenzie C Role of interferon alpha in promoting T helper cell type I responses in the small intestine in coeliac disease. Gut 2001; 48: 425-429. (Pubitemid 32269575)
15. Maiuri L, Ciacci C, Auricchio S, Brown V, Quarantino S, Londei M. Interleukin-15 mediates epithelial changes in celiac disease. Gastroenterology 2000; 119: 996-1006.
16. Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006; 101: 2333-2340. (Pubitemid 44477562)
17. Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to chemokine receptor CXCR3. Gastroenterology 2008; 135: 194-204.
18. Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity. Celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci 2009; 1165: 195-205.
19. Stamnaes J, Dorum S, Fleckenstein B, Aeshlimann D, Solid LM. Gluten Tcell epitope targetingbyTG3andTG6; implicationsfordermatitisherpetiformisandglutenataxia. Amino Acids 2010; 39: 1183-1191.
20. Simpson M, Mojibian M, Barriga K, Scott FW, Fasano A, Rewers M et al. Anexploration of Glo-3A antibdy levels in children at increased risk for type 1 diabetes. Pediatr Diabetes 2009; 10: 563-572.
21. Arnson Y, Shoenfeld Y, Amital H. Effectsoftobaccosmokeon immunity, inflammation and autoimmunity. J Autoimmun 2010; 34: J258-J265.
22. Berkun Y, Padeh S. Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 2010; 9: A319-A324.
23. Bhat A, Naguwa S, Cheema G, Gershwin ME. Theepidemiologyof transversemyelitis. Autoimmun Rev 2010; 9: A395-A399.
24. Biggioggero M, Meroni PL. The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 2010; 9: A299-A304.
25. Borchers AT, Naguwa SM, Keen CL, Gershwin ME. The implicationsof autoimmunity and pregnancy. J Autoimmun 2010; 34: J287-J299.
26. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010; 9: A277-A287.
27. Borchers AT, Uibo R, Gershwin ME. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010; 9: A355-A365.
28. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010; 34: J207-J219.
29. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34: J314-J321.
30. Chang C The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 2010; 34: J234-J246.
31. Chang C, Gershwin ME. Drugs and autoimmunity\a contemporary review and mechanistic approach. J Autoimmun 2010; 34: J266-J275.
32. Chen M, Daha MR, Kallenberg CG. Thecomplementsystem in systemic autoimmune disease. J Autoimmun 2010; 34: J276-J286.
33. Chen M, Kallenberg CG. The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 2010; 9: A293-A298.
34. Deane S, Teuber SS, Gershwin ME. The geoepidemiology of immune throm-bocytopenic purpura. Autoimmun Rev 2010; 9: A342-A349.
35. Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 2010; 9: A325-A329.
36. Hemminki K, Li X, Sundquist J, Sundquist K. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 2010; 34: J307-J313.
37. Hoffmann MH, Trembleau S, Muller S, Steiner G. Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun 2010; 34: J178-J206.
38. Invernizzi P. Geoepidemiologyof autoimmune liverdiseases. J Autoimmun 2010; 34: J300-J306.
39. Lambert JF, Nydegger UE. Geoepidemiology of autoimmune hemolytic anemia. Autoimmun Rev 2010; 9: A350-A354.
40. Leung PS, Shu SA, Kenny TP, Wu PY, Tao MH. Development and validation of gene therapies in autoimmunediseases: epidemiologyto animal models. Autoimmun Rev 2010; 9: A400-A405.
41. Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME. Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev 2010; 9: A259-A266.
42. Logan I, Bowlus CL. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010; 9: A372-A378.
43. Mackay IR. Travelsandtravailsof autoimmunity: ahistorical journeyfromdiscoveryto rediscovery. Autoimmun Rev 2010; 9: A251-A258.
44. Maverakis E, Miyamura Y, Bowen MP, Correa G, Ono Y, Goodarzi H. Light, including ultraviolet. J Autoimmun 2010; 34: J247-J257.
45. Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 2010; 9: A305-A310.
46. Meyer A, Levy Y. Chapter 33: geoepidemiologyof myasthenia gravis. Autoimmun Rev 2010; 9: A383-A386.
47. Meyer N, Misery L. Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 2010; 9: A379-A382.
48. Milo R, Kahana E. Multiplesclerosis:geoepidemiology, genetics and the environment. Autoimmun Rev 2010; 9: A387-A394.
49. Powell JJ, Faria N, Thomas-McKay E, Pele LC. Originand fateof dietarynanoparticles and microparticles inthegastrointestinal tract. J Autoimmun 2010; 34: J226-J233.
50. Prieto S, Grau JM. The geoepidemiology of auto immunemuscle disease. Autoimmun Rev 2010; 9: A330-A334.
51. Ranque B, Mouthon L. Geoepidemiologyof systemicsclerosis. Autoimmun Rev 2010; 9: A311-A318.
52. Round JL, O'Connell RM, Mazmanian SK. Coordination of tolerogenic immune responses by thecommensal microbiota. J Autoimmun 2010; 34: J220-J225.
53. Sands J, Tuscano JM. Geoepidemiology and autoimmune manifestations of lymphoproliferativedisorders. Autoimmun Rev 2010; 9: A335-A341.
54. Segelmark M, Hellmark T. Autoimmune kidney diseases. Autoimmun Rev 2010; 9: A366-A371.
55. Selmi C. The world wideg radient of auto immuneconditions. Autoimmun Rev 2010;9: A247-A250.
56. Selmi C, Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010; 9: A267-A270.
57. Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010; 34: J168-J177.
58. Stojanovich L. Stress and autoimmunity. Autoimmun Rev 2010; 9: A271-A276.
59. Tobon GJ, Youinou P, Saraux A.Theenvironment, geo-epidemiology, andautoimmune disease: rheumatoid arthritis. Autoimmun Rev 2010; 9: A288-A292.
60. Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010; 34: J322-J326.
61. Youinou P, Pers JO, Gershwin ME, Shoenfeld Y. Geo- epidemiologyandautoimmunity. J Autoimmun 2010; 34: J163-J167.
62. Zeki AA, Schivo M, Chan AL, Hardin KA, Kenyon NJ, Albertson TE, et al. Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 2010; 34: J327-J338.